<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">Researchers and scientists across the world are focusing on repurposing the existing drugs, passive immunity and looking for vaccines against the virus (
 <xref rid="bib57" ref-type="bibr">Harrison 2020</xref>). Among the available drugs, for instance, the antimalarials Chloroquine and hydroxychloroquine received attention after studies on its efficacy were conducted recently (
 <xref rid="bib50" ref-type="bibr">Gautret et al., 2020</xref>; 
 <xref rid="bib71" ref-type="bibr">Keyaerts et al., 2004</xref>; 
 <xref rid="bib138" ref-type="bibr">Wang et al., 2020</xref>). However, the medication soon became controversial regarding its efficacy and manifestations of side effects such as fulminant hepatic failure, serious cutaneous adverse reactions, and ventricular arrhythmias (
 <xref rid="bib45" ref-type="bibr">Ferner and Aronson 2020</xref>).
</p>
